Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Cuevas

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Neurological Research|June 17, 2004
Differentiation-inducing activity of neomycin in cultured rat glioma cellsPedro Cuevas, Diana Díaz-González, Manuel Dujovny
BMJ Case Reports|June 8, 2012
Long-term effectiveness of dobesilate in the treatment of papulopustular rosaceaPedro Cuevas, Javier Angulo, Guillermo Giménez-Gallego
Neurological Research|February 5, 2003
Dual blockade of mitogen-activated protein kinases ERK-1 (p42) and ERK-2 (p44) and cyclic AMP response element binding protein (CREB) by neomycin inhibits glioma cell proliferationPedro Cuevas, Diana Diaz-González, Fernando Carceller, et al.
Neurological Research|February 25, 2005
Perivascular delivery of neomycin inhibits the activation of NF-kappaB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injuryJorge García-Trapero, Fernando Carceller, Manuel Dujovny, et al.
BMJ Case Reports|June 26, 2012
Clearance of seborrhoeic keratoses with topical dobesilatePedro Cuevas, Javier Angulo, Irene Salgüero, et al.
BMJ Case Reports|September 7, 2012
Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancerPedro Cuevas, Antonio Sueiro, Pilar Navío, et al.
BMJ Case Reports|September 6, 2012
Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two casesPedro Cuevas, Luis Outeiriño, Carlos Azanza, et al.
BMJ Case Reports|July 11, 2012
Chronic cystoid macular oedema treated with intravitreal dobesilatePedro Cuevas, Luis A Outeiriño, Javier Angulo, et al.
European Journal of Medical Research|September 27, 2005
Dobesilate is an angiogenesis inhibitorPedro Cuevas, I Sanchez, R M Lozano, et al.
BMJ Case Reports|May 19, 2012
Topical dobesilate eye drops for ophthalmic primary pterygiumPedro Cuevas, Luis A Outeiriño, Javier Angulo, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Neurological Research|June 17, 2004
Differentiation-inducing activity of neomycin in cultured rat glioma cellsPedro Cuevas, Diana Díaz-González, Manuel Dujovny
BMJ Case Reports|June 8, 2012
Long-term effectiveness of dobesilate in the treatment of papulopustular rosaceaPedro Cuevas, Javier Angulo, Guillermo Giménez-Gallego
Neurological Research|February 5, 2003
Dual blockade of mitogen-activated protein kinases ERK-1 (p42) and ERK-2 (p44) and cyclic AMP response element binding protein (CREB) by neomycin inhibits glioma cell proliferationPedro Cuevas, Diana Diaz-González, Fernando Carceller, et al.
Neurological Research|February 25, 2005
Perivascular delivery of neomycin inhibits the activation of NF-kappaB and MAPK pathways, and prevents neointimal hyperplasia and stenosis after arterial injuryJorge García-Trapero, Fernando Carceller, Manuel Dujovny, et al.
BMJ Case Reports|June 26, 2012
Clearance of seborrhoeic keratoses with topical dobesilatePedro Cuevas, Javier Angulo, Irene Salgüero, et al.
BMJ Case Reports|September 7, 2012
Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancerPedro Cuevas, Antonio Sueiro, Pilar Navío, et al.
BMJ Case Reports|September 6, 2012
Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two casesPedro Cuevas, Luis Outeiriño, Carlos Azanza, et al.
BMJ Case Reports|July 11, 2012
Chronic cystoid macular oedema treated with intravitreal dobesilatePedro Cuevas, Luis A Outeiriño, Javier Angulo, et al.
European Journal of Medical Research|September 27, 2005
Dobesilate is an angiogenesis inhibitorPedro Cuevas, I Sanchez, R M Lozano, et al.
BMJ Case Reports|May 19, 2012
Topical dobesilate eye drops for ophthalmic primary pterygiumPedro Cuevas, Luis A Outeiriño, Javier Angulo, et al.
Pageof 7